World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
75
Citations
17335
World Ranking
5402
National Ranking
417

Medicine

D-Index
75
Citations
18209
World Ranking
19191
National Ranking
1733

John R. Atack publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where John R. Atack sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 302 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

John R. Atack D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where John R. Atack sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 75 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

John R. Atack is a researcher affiliated with Cardiff University in the United Kingdom. Their work primarily spans the fields of Biochemistry, Genetics and Molecular Biology, Neuroscience, and Medicine, with a significant focus on Molecular Biology and Cellular and Molecular Neuroscience.

Their recent scholarly output includes a variety of publications across multiple reputable venues. Notable papers include:

  • Relating neurosteroid modulation of inhibitory neurotransmission to behaviour, 2021, Journal of Neuroendocrinology
  • Multi-patient dose synthesis of [18F]Flumazenil via a copper-mediated 18F-fluorination, 2022, EJNMMI Radiopharmacy and Chemistry
  • Comparative Analysis of Small-Molecule LIMK1/2 Inhibitors: Chemical Synthesis, Biochemistry, and Cellular Activity, 2022, Journal of Medicinal Chemistry
  • A toolkit for the identification of NEAT1_2/paraspeckle modulators, 2022, Nucleic Acids Research
  • Inhibition of a tonic inhibitory conductance in mouse hippocampal neurones by negative allosteric modulators of α5 subunit-containing γ-aminobutyric acid type A receptors: implications for treating cognitive deficits, 2020, British Journal of Anaesthesia

John R. Atack frequently collaborates with a consistent group of co-authors. These include Simon E. Ward, Jason A. Gillespie, Loren Waters, Olivera Grubisha, and Karen T Elvers, all of whom have co-authored multiple works with them.

Their publication activity is concentrated in prominent journals such as the Journal of Medicinal Chemistry, bioRxiv (Cold Spring Harbor Laboratory), Journal of Neuroendocrinology, Nucleic Acids Research, and Neuroscience Letters.

The core topics addressed in their research encompass:

  • Neuroscience and Neuropharmacology Research
  • Enzyme Structure and Function
  • Amino Acid Enzymes and Metabolism
  • Cellular Mechanics and Interactions
  • Cardiomyopathy and Myosin Studies
  • Protein Kinase Regulation and GTPase Signaling
  • Neuroendocrine regulation and behavior

Within their molecular and cellular studies, John R. Atack focuses on aspects such as enzyme mechanisms, receptor modulation, and chemical synthesis related to neuropharmacological functions. Their publications reveal interdisciplinary approaches combining biochemistry, molecular biology, and medicinal chemistry, particularly emphasizing enzyme and receptor activity regulation relevant to neurobiology.

Best Publications

  • Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

    R M McKernan;T W Rosahl;D S Reynolds;C Sur

  • Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

    E K Perry;M Curtis;D J Dick;J M Candy

  • Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABAAReceptor

    Neil Collinson;Frederick M. Kuenzi;Wolfgang Jarolimek;Karen A. Maubach

  • Aluminosilicates and senile plaque formation in Alzheimer's disease.

    J.M. Candy;J. Klinowski;R.H. Perry;E.K. Perry

  • Cerebrospinal fluid production is reduced in healthy aging.

    C. May;J. A. Kaye;John R. Atack;M. B. Schapiro

  • Sedation and Anesthesia Mediated by Distinct GABAA Receptor Isoforms

    David S. Reynolds;Thomas W. Rosahl;Jennifer Cirone;Gillian F. O'Meara

  • Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus.

    Cyrille Sur;Sophie J. Farrar;Julie Kerby;Paul J. Whiting

  • Evidence for a Significant Role of α3-Containing GABAA Receptors in Mediating the Anxiolytic Effects of Benzodiazepines

    Rebecca Dias;Wayne F. A. Sheppard;Rosa L. Fradley;Elizabeth M. Garrett

  • An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

    G. R. Dawson;K. A. Maubach;N. Collinson;M. Cobain

  • Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: Selective loss of the intermediate (10S) form

    John R. Atack;Elaine K. Perry;James R. Bonham;Robert H. Perry

  • Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice.

    Cyrille Sur;Keith A. Wafford;David S. Reynolds;Karen L. Hadingham

  • TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.

    John R. Atack;Keith A. Wafford;Spencer J. Tye;Susan M. Cook

  • Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates.

    James K. Rowlett;Donna M. Platt;Snjezana Lelas;John R. Atack

  • Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System

    John R. Atack;Elaine K. Perry;James R. Bonham;John M. Candy

  • The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics.

    John R Atack

  • Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study.

    Peter J. Whitehouse;A. M. Martino;M. V. Wagster;D. L. Price

  • The complexity of the GABAA receptor shapes unique pharmacological profiles.

    Charlotte D’Hulst;John R. Atack;R. Frank Kooy

  • Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.

    Pascal Bonaventure;Lisa Kelly;Leah Aluisio;Jonathan Shelton

  • L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors

    John R. Atack;Peter J. Bayley;Guy R. Seabrook;Keith A. Wafford

  • Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux.

    Alison J. Smith;Luanda Alder;Jonathan Silk;Charles Adkins

Frequent Co-Authors

Ruth M. McKernan
Ruth M. McKernan MSD (United States)
Keith A. Wafford
Keith A. Wafford Eli Lilly (United States)
Gerard R. Dawson
Gerard R. Dawson P1vital LTD
Paul J. Whiting
Paul J. Whiting University College London
Richard Hargreaves
Richard Hargreaves Harvard Medical School
Thomas W. Rosahl
Thomas W. Rosahl MSD (United States)
Angus Murray Macleod
Angus Murray Macleod MSD (United States)
Elaine K. Perry
Elaine K. Perry Newcastle University
Robert H. Perry
Robert H. Perry Newcastle University
Stanley I. Rapoport
Stanley I. Rapoport National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing John R. Atack

Trending Scientists

Recently Published Articles